Bioventus

BVS56

$11.69arrow_drop_up0.04%$0.00

BVS56

$11.69

arrow_drop_up0.04%$0.00

Performance History

Key Stats
Open	$11.42
Prev. Close	$11.37
EPS	-0.65
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	11.27	11.99
52 Week Range	2.82	11.99

Ratios







EPS	-0.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Bioventus (BVS)

Bioventus Inc. (BVS) is a leading global medical device company that develops, manufactures, and markets innovative orthobiologic solutions for musculoskeletal healing and regeneration. With a strong focus on patient outcomes and evidence-based medicine, Bioventus is dedicated to improving the lives of patients suffering from orthopedic conditions. The company's products are designed to promote natural healing processes and enhance patient recovery. Bioventus has a diverse portfolio of products that address a range of indications, including osteoarthritis, chronic pain, and bone fractures.

One of Bioventus' flagship products is EXOGEN, a bone healing system that uses low-intensity pulsed ultrasound technology to accelerate the healing of fractures. EXOGEN has been clinically proven to significantly reduce healing time and improve patient outcomes. Another key product in Bioventus' portfolio is DUROLANE, a single-injection, hyaluronic acid-based treatment for knee osteoarthritis. DUROLANE provides long-lasting pain relief and improved joint function for patients suffering from this debilitating condition.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Anthony P. Bihl III
Headquarters: Durham
Employees: 950
Exchange: NASDAQ

Keep an eye on Bioventus

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Bioventus (BVS)?

For Bioventus (BVS), the 52-week high is $12.03, which is 2.87% from the current price. The 52-week low is $2.82, the current price is 314.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Bioventus (BVS) a growth stock?

Bioventus (BVS) has shown an average price growth of 0.41% over the past three years. It has received a score of 93 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bioventus as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Bioventus (BVS) stock price performance year to date (YTD)?

As of the latest data, Bioventus (BVS) has a year-to-date price change of 122.76%. Over the past month, the stock has experienced a price change of 46.18%. Over the last three months, the change has been 100.94%. Over the past six months, the figure is 113.02%.

help

Is Bioventus (BVS) a profitable company?

Bioventus (BVS) has a net income of -$96.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 62.33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.12% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $512.34M, with a revenue growth rate of 0.04%, providing insight into the company's sales performance and growth. The gross profit is $319.35M. Operating income is noted at $16.01M. Furthermore, the EBITDA is $65.86M.

help

What is the market capitalization of Bioventus (BVS)?

Bioventus (BVS) has a market capitalization of $741.18M. The average daily trading volume is 457.67K, indicating the stock's liquidity and investor engagement.

help

What is Bioventus's (BVS) price per share?

The current price per share for Bioventus (BVS) is $11.69. The stock has seen a price change of $0 recently, indicating a 0.04% change. This reflects the stock's recent market performance and investor sentiment.